A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancers With HER2 Expression
Interventions: DRUG: BAY2701439|DRUG: BAY2701439
Sponsor: Bayer